Luminari | Human Judgment. Machine Speed. Luminari is an AI technology company building the intelligence infrastructure for drug and medical product development. We’re not building another AI application for life sciences - we’re connecting technology to the full complexity of how therapies actually reach patients. That starts with people. Our team has led work across clinical development, regulatory affairs, biostatistics, medical devices, pharma, CRO operations and AI engineering, and that expertise is built into the technology, not layered on top of it. Our flagship product, LumiPath™, is built on more than 10,000 regulatory documents. It supports clinical trial protocol and regulatory document development, producing structured, regulatory-aligned drafts built around FDA, EMA and ICH requirements, which expert teams review and finalize. AI is the connective tissue. It links scientific, clinical, operational, and regulatory workflows that have always operated in silos, and it’s built for how development actually happens: distributed across sponsors, CROs, sites, regulators, and geographies. It’s also human in the loop by design. AI augments scientific and clinical judgment; it doesn’t replace it. The system gets smarter as experts use it, while accountability stays with the people who understand the science and the patient. What LumiPath™ delivers: • Protocol and study design generation • Regulatory document generation • Authoring, editing and review agents • A reference library and Ask Lumina™, an assistant for protocol and clinical trial questions Our mission is simple: save lives by shortening the path from discovery to bedside. Headquartered in Wheeling, Illinois. Accepted into the NVIDIA Inception Program in 2026. Learn more or get in touch at www.luminaricro.com